4//SEC Filing
Mendel Scott 4
Accession 0001562180-25-005379
CIK 0001503274other
Filed
Jul 9, 8:00 PM ET
Accepted
Jul 10, 8:39 PM ET
Size
12.7 KB
Accession
0001562180-25-005379
Insider Transaction Report
Form 4
Quanterix CorpQTRX
Mendel Scott
Director
Transactions
- Award
Common Stock
2025-07-08+4,189→ 4,189 total - Award
Stock Option (right to buy)
2025-07-08+50,758→ 50,758 totalExercise: $6.54Exp: 2035-07-08→ Common Stock (50,578 underlying) - Award
Common Stock
2025-07-08+24,464→ 28,653 total
Footnotes (4)
- [F1]Received in exchange for 28,500 shares of Akoya Biosciences, Inc. ("Akoya") common stock in connection with the acquisition of Akoya by Quanterix on July 8, 2025. Mr. Mendel received: (a) 0.1470 of a share of Quanterix common stock and (b) $0.37 in cash, for each share of Akoya common stock. The closing price of the Quanterix common stock on July 8, 2025 was $6.54 per share. The closing price of the Akoya common stock on July 7, 2025 was $1.29 per share.
- [F2]Represents shares of stock issuable on vesting of restricted stock units. The restricted stock units vest as to one-third of the shares on each of July 8, 2026, July 8, 2027 and July 8, 2028.
- [F3]Includes 24,464 restricted stock units.
- [F4]The option vests as to one-third of the shares on July 8, 2026, and the remaining two-thirds of the shares vest monthly thereafter over two years in 24 successive equal installments.
Issuer
Quanterix Corp
CIK 0001503274
Entity typeother
Related Parties
1- filerCIK 0001515051
Filing Metadata
- Form type
- 4
- Filed
- Jul 9, 8:00 PM ET
- Accepted
- Jul 10, 8:39 PM ET
- Size
- 12.7 KB